Skip Navigation
Skip to contents

JMD : Journal of Movement Disorders

OPEN ACCESS
SEARCH
Search

Previous issues

Page Path
HOME > Browse Articles > Previous issues
11 Previous issues
Filter
Filter
Article category
Keywords
Authors
Funded articles
Volume 12(3); September 2019
Prev issue Next issue
Review Articles
Modeling α-Synuclein Propagation with Preformed Fibril Injections
Hyun Kyung Chung, Hoang-Anh Ho, Dayana Pérez-Acuña, Seung-Jae Lee
J Mov Disord. 2019;12(3):139-151.   Published online September 30, 2019
DOI: https://doi.org/10.14802/jmd.19046
Correction in: J Mov Disord 2020;13(1):77
  • 17,694 View
  • 912 Download
  • 59 Web of Science
  • 56 Crossref
AbstractAbstract PDF
The aggregation of α-synuclein (α-syn) has been implicated in the pathogenesis of many neurodegenerative disorders, including Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). Postmortem analyses of α-syn pathology, especially that of PD, have suggested that aggregates progressively spread from a few discrete locations to wider brain regions. The neuron-to-neuron propagation of α-syn has been suggested to be the underlying mechanism by which aggregates spread throughout the brain. Many cellular and animal models has been created to study cell-to-cell propagation. Recently, it has been shown that a single injection of preformed fibrils (PFFs) made of recombinant α-syn proteins into various tissues and organs of many different animal species results in widespread α-syn pathology in the central nervous system (CNS). These PFF models have been extensively used to study the mechanism by which aggregates spread throughout the brain. Here, we review what we have learned from PFF models, describe the nature of PFFs and the neuropathological features, neurophysiological characteristics, and behavioral outcomes of the models.

Citations

Citations to this article as recorded by  
  • Glial senescence enhances α-synuclein pathology owing to its insufficient clearance caused by autophagy dysfunction
    Bin Hong, Yosuke Ohtake, Takahide Itokazu, Toshihide Yamashita
    Cell Death Discovery.2024;[Epub]     CrossRef
  • A Surface Imprinted Polymer EIS Sensor for Detecting Alpha-Synuclein, a Parkinson’s Disease Biomarker
    Roslyn Simone Massey, Rishabh Ramesh Appadurai, Ravi Prakash
    Micromachines.2024; 15(2): 273.     CrossRef
  • Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration
    Nasir Uddin Mahbub, Md Minarul Islam, Seong-Tshool Hong, Hea-Jong Chung
    Frontiers in Cellular and Infection Microbiology.2024;[Epub]     CrossRef
  • Neuropathogenesis-on-chips for neurodegenerative diseases
    Sarnai Amartumur, Huong Nguyen, Thuy Huynh, Testaverde S. Kim, Ran-Sook Woo, Eungseok Oh, Kyeong Kyu Kim, Luke P. Lee, Chaejeong Heo
    Nature Communications.2024;[Epub]     CrossRef
  • Systemic inflammation activates coagulation and immune cell infiltration pathways in brains with propagating α-synuclein fibril aggregates
    Anne-Line Strange Laursen, Mikkel Vestergaard Olesen, Jonas Folke, Tomasz Brudek, Luisa Harriet Knecht, Florence Sotty, Kate Lykke Lambertsen, Karina Fog, Louise Torp Dalgaard, Susana Aznar
    Molecular and Cellular Neuroscience.2024; 129: 103931.     CrossRef
  • Comparison of Aptamer and Antibody Bioreceptors in the OEGFET Biosensor Platform for Detecting α-Synuclein, a Parkinson's Biomarker
    Roslyn S. Massey, Srishti Johri, Dennis Chan, Matthew R. Holahan, Ravi Prakash
    IEEE Sensors Letters.2024; 8(7): 1.     CrossRef
  • Non-invasive Monitoring of α-Synuclein in Saliva for Parkinson’s Disease Using Organic Electrolyte-Gated FET Aptasensor
    Roslyn S. Massey, Erin M. McConnell, Dennis Chan, Matthew R. Holahan, Maria C. DeRosa, Ravi Prakash
    ACS Sensors.2023; 8(8): 3116.     CrossRef
  • CSF-derived extracellular vesicles from patients with Parkinson’s disease induce symptoms and pathology
    Shay Herman, Ruth Djaldetti, Brit Mollenhauer, Daniel Offen
    Brain.2023; 146(1): 209.     CrossRef
  • Overexpression-Induced α-Synuclein Brain Spreading
    Rita Pinto-Costa, Eugenia Harbachova, Pietro La Vitola, Donato A. Di Monte
    Neurotherapeutics.2023; 20(1): 83.     CrossRef
  • The Role of α-Synuclein in the Regulation of Serotonin System: Physiological and Pathological Features
    Lluis Miquel-Rio, Unai Sarriés-Serrano, Rubén Pavia-Collado, J Javier Meana, Analia Bortolozzi
    Biomedicines.2023; 11(2): 541.     CrossRef
  • α‐Synuclein decoy peptide protects mice against α‐synuclein‐induced memory loss
    Qingyun Guo, Ichiro Kawahata, Wenbin Jia, Haoyang Wang, An Cheng, Yasushi Yabuki, Norifumi Shioda, Kohji Fukunaga
    CNS Neuroscience & Therapeutics.2023; 29(6): 1547.     CrossRef
  • Duodenal alpha‐Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease
    Aron Emmi, Michele Sandre, Francesco Paolo Russo, Giulia Tombesi, Federica Garrì, Marta Campagnolo, Miryam Carecchio, Roberta Biundo, Gaya Spolverato, Veronica Macchi, Edoardo Savarino, Fabio Farinati, Piero Parchi, Andrea Porzionato, Luigi Bubacco, Raffa
    Movement Disorders.2023; 38(5): 885.     CrossRef
  • Retina-to-brain spreading of α-synuclein after intravitreal injection of preformed fibrils
    Dayana Pérez-Acuña, Ka Hyun Rhee, Soo Jean Shin, Jeeyun Ahn, Jee-Young Lee, Seung-Jae Lee
    Acta Neuropathologica Communications.2023;[Epub]     CrossRef
  • Apathy in Parkinson’s Disease: Clinical Patterns and Neurobiological Basis
    Matthieu Béreau, Vincent Van Waes, Mathieu Servant, Eloi Magnin, Laurent Tatu, Mathieu Anheim
    Cells.2023; 12(12): 1599.     CrossRef
  • Translating Pathological Brain Activity Primers in Parkinson’s Disease Research
    Daniela Mirzac, Svenja L. Kreis, Heiko J. Luhmann, Gabriel Gonzalez-Escamilla, Sergiu Groppa
    Research.2023;[Epub]     CrossRef
  • Animal models of Parkinson’s disease: bridging the gap between disease hallmarks and research questions
    Axelle Dovonou, Cyril Bolduc, Victoria Soto Linan, Charles Gora, Modesto R. Peralta III, Martin Lévesque
    Translational Neurodegeneration.2023;[Epub]     CrossRef
  • The Poly-Arginine Peptide R18D Interferes with the Internalisation of α-Synuclein Pre-Formed Fibrils in STC-1 Enteroendocrine Cells
    Anastazja M. Gorecki, Holly Spencer, Bruno P. Meloni, Ryan S. Anderton
    Biomedicines.2023; 11(8): 2089.     CrossRef
  • Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain
    Shuyu Zhang, Karina Dauer, Timo Strohäker, Lars Tatenhorst, Lucas Caldi Gomes, Simon Mayer, Byung Chul Jung, Woojin S. Kim, Seung‐Jae Lee, Stefan Becker, Friederike Liesche‐Starnecker, Markus Zweckstetter, Paul Lingor
    Brain Pathology.2023;[Epub]     CrossRef
  • Aging, Parkinson’s Disease, and Models: What Are the Challenges?
    Emily Rocha, Manish Chamoli, Shankar J. Chinta, Julie K. Andersen, Ruby Wallis, Erwan Bezard, Matt Goldberg, Tim Greenamyre, Warren Hirst, We-Li Kuan, Deniz Kirik, Laura Niedernhofer, Irit Rappley, Shalini Padmanabhan, Louis-Eric Trudeau, Maria Spillantin
    Aging Biology.2023; 1(1): 20230010.     CrossRef
  • A Novel NOX Inhibitor Alleviates Parkinson’s Disease Pathology in PFF-Injected Mice
    Kwadwo Ofori, Anurupa Ghosh, Dinesh Kumar Verma, Darice Wheeler, Gabriela Cabrera, Jong-Bok Seo, Yong-Hwan Kim
    International Journal of Molecular Sciences.2023; 24(18): 14278.     CrossRef
  • Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain
    Margaux Teil, Sandra Dovero, Mathieu Bourdenx, Marie-Laure Arotcarena, Morgane Darricau, Gregory Porras, Marie-Laure Thiolat, Inés Trigo-Damas, Celine Perier, Cristina Estrada, Nuria Garcia-Carrillo, María Trinidad Herrero, Miquel Vila, José A. Obeso, Erw
    npj Parkinson's Disease.2023;[Epub]     CrossRef
  • Immunization Effects of a Novel α-Synuclein-Based Peptide Epitope Vaccine in Parkinson’s Disease-Associated Pathology
    Jun Sung Park, Riaz Ahmad, Kyonghwan Choe, Min Hwa Kang, Tae Ju Park, Myeong Ok Kim
    Vaccines.2023; 11(12): 1820.     CrossRef
  • Ellagic Acid Prevents α-Synuclein Spread and Mitigates Toxicity by Enhancing Autophagic Flux in an Animal Model of Parkinson’s Disease
    Nada Radwan, Engila Khan, Mustafa T. Ardah, Tohru Kitada, M. Emdadul Haque
    Nutrients.2023; 16(1): 85.     CrossRef
  • DA-9805 protects dopaminergic neurons from endoplasmic reticulum stress and inflammation
    Sora Kang, Ying Piao, Young Cheol Kang, Suyeol Lim, Youngmi Kim Pak
    Biomedicine & Pharmacotherapy.2022; 145: 112389.     CrossRef
  • Endogenous Levels of Alpha-Synuclein Modulate Seeding and Aggregation in Cultured Cells
    Eftychia Vasili, Antonio Dominguez-Meijide, Manuel Flores-León, Mohammed Al-Azzani, Angeliki Kanellidi, Ronald Melki, Leonidas Stefanis, Tiago Fleming Outeiro
    Molecular Neurobiology.2022; 59(2): 1273.     CrossRef
  • Phosphorylation of endogenous α-synuclein induced by extracellular seeds initiates at the pre-synaptic region and spreads to the cell body
    Shiori Awa, Genjiro Suzuki, Masami Masuda-Suzukake, Takashi Nonaka, Minoru Saito, Masato Hasegawa
    Scientific Reports.2022;[Epub]     CrossRef
  • Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy
    Thuy Thi Lai, Yun Joong Kim, Hyeo-il Ma, Young Eun Kim
    Journal of Movement Disorders.2022; 15(1): 1.     CrossRef
  • α-Synuclein in Parkinson's disease and advances in detection
    Rong Chen, Xuan Gu, Xiaoying Wang
    Clinica Chimica Acta.2022; 529: 76.     CrossRef
  • Neurons with Cat’s Eyes: A Synthetic Strain of α-Synuclein Fibrils Seeding Neuronal Intranuclear Inclusions
    Francesca De Giorgi, Muhammed Bilal Abdul-Shukkoor, Marianna Kashyrina, Leslie-Ann Largitte, Francesco De Nuccio, Brice Kauffmann, Alons Lends, Florent Laferrière, Sébastien Bonhommeau, Dario Domenico Lofrumento, Luc Bousset, Erwan Bezard, Thierry Buffete
    Biomolecules.2022; 12(3): 436.     CrossRef
  • A Novel NOX Inhibitor Treatment Attenuates Parkinson’s Disease-Related Pathology in Mouse Models
    Anurupa A. Ghosh, Dinesh Kumar Verma, Gabriela Cabrera, Kwadwo Ofori, Karina Hernandez-Quijada, Jae-Kwan Kim, Joo Hee Chung, Michael Moore, Sung Hwan Moon, Jong Bok Seo, Yong-Hwan Kim
    International Journal of Molecular Sciences.2022; 23(8): 4262.     CrossRef
  • Do Naturally Occurring Antioxidants Protect Against Neurodegeneration of the Dopaminergic System? A Systematic Revision in Animal Models of Parkinson's Disease
    Carmen Costas, Lilian R.F. Faro
    Current Neuropharmacology.2022; 20(2): 432.     CrossRef
  • NXP031 prevents dopaminergic neuronal loss and oxidative damage in the AAV-WT-α-synuclein mouse model of Parkinson’s disease
    Min Kyung Song, Levi Adams, Joo Hee Lee, Yoon-Seong Kim, Hemant K. Paudel
    PLOS ONE.2022; 17(7): e0272085.     CrossRef
  • Stress-inducible phosphoprotein 1 (HOP/STI1/STIP1) regulates the accumulation and toxicity of α-synuclein in vivo
    Rachel E. Lackie, Aline S. de Miranda, Mei Peng Lim, Vladislav Novikov, Nimrod Madrer, Nadun C. Karunatilleke, Benjamin S. Rutledge, Stephanie Tullo, Anne Brickenden, Matthew E. R. Maitland, David Greenberg, Daniel Gallino, Wen Luo, Anoosha Attaran, Irina
    Acta Neuropathologica.2022; 144(5): 881.     CrossRef
  • Nanomedicine in the Face of Parkinson’s Disease: From Drug Delivery Systems to Nanozymes
    Francisco J. Padilla-Godínez, Leonardo I. Ruiz-Ortega, Magdalena Guerra-Crespo
    Cells.2022; 11(21): 3445.     CrossRef
  • Animal Models of Metabolic Disorders in the Study of Neurodegenerative Diseases: An Overview
    Andreza Fabro de Bem, Rachel Krolow, Hémelin Resende Farias, Victória Linden de Rezende, Daniel Pens Gelain, José Cláudio Fonseca Moreira, João Miguel das Neves Duarte, Jade de Oliveira
    Frontiers in Neuroscience.2021;[Epub]     CrossRef
  • Role of Liver Growth Factor (LGF) in Parkinson’s Disease: Molecular Insights and Therapeutic Opportunities
    Efthalia Angelopoulou, Yam Nath Paudel, Christina Piperi
    Molecular Neurobiology.2021; 58(7): 3031.     CrossRef
  • Trans-synaptic spreading of alpha-synuclein pathology through sensory afferents leads to sensory nerve degeneration and neuropathic pain
    Nelson Ferreira, Nádia Pereira Gonçalves, Asad Jan, Nanna Møller Jensen, Amelia van der Laan, Simin Mohseni, Christian Bjerggaard Vægter, Poul Henning Jensen
    Acta Neuropathologica Communications.2021;[Epub]     CrossRef
  • Pharmacological Inhibition of Brain EGFR Activation By a BBB-penetrating Inhibitor, AZD3759, Attenuates α-synuclein Pathology in a Mouse Model of α-Synuclein Propagation
    Omid Tavassoly, Esther del Cid Pellitero, Frederique Larroquette, Eddie Cai, Rhalena A. Thomas, Vincent Soubannier, Wen Luo, Thomas M. Durcan, Edward A. Fon
    Neurotherapeutics.2021; 18(2): 979.     CrossRef
  • The Future of Incretin-Based Approaches for Neurodegenerative Diseases in Older Adults: Which to Choose? A Review of their Potential Efficacy and Suitability
    Christine Girges, Nirosen Vijiaratnam, Dilan Athauda, Grace Auld, Sonia Gandhi, Thomas Foltynie
    Drugs & Aging.2021; 38(5): 355.     CrossRef
  • Prodromal neuroinvasion of pathological α-synuclein in brainstem reticular nuclei and white matter lesions in a model of α-synucleinopathy
    Nelson Ferreira, Mette Richner, Amelia van der Laan, Ida Bergholdt Jul Christiansen, Christian B Vægter, Jens R Nyengaard, Glenda M Halliday, Joachim Weis, Benoit I Giasson, Ian R Mackenzie, Poul H Jensen, Asad Jan
    Brain Communications.2021;[Epub]     CrossRef
  • Impact of the apelin/APJ axis in the pathogenesis of Parkinson’s disease with therapeutic potential
    Efthalia Angelopoulou, Yam Nath Paudel, Anastasia Bougea, Christina Piperi
    Journal of Neuroscience Research.2021; 99(9): 2117.     CrossRef
  • Adenovirus-induced Reactive Astrogliosis Exacerbates the Pathology of Parkinson’s Disease
    Heeyoung An, Hyowon Lee, Seulkee Yang, Woojin Won, C. Justin Lee, Min-Ho Nam
    Experimental Neurobiology.2021; 30(3): 222.     CrossRef
  • Brain iron enrichment attenuates α‐synuclein spreading after injection of preformed fibrils
    Karina Dauer née Joppe, Lars Tatenhorst, Lucas Caldi Gomes, Shuyu Zhang, Mojan Parvaz, Eleonora Carboni, Anna‐Elisa Roser, Hazem El DeBakey, Mathias Bähr, Katarina Vogel‐Mikuš, Chi Wang Ip, Stefan Becker, Markus Zweckstetter, Paul Lingor
    Journal of Neurochemistry.2021; 159(3): 554.     CrossRef
  • Increased oscillatory power in a computational model of the olfactory bulb due to synaptic degeneration
    J. Kendall Berry, Daniel Cox
    Physical Review E.2021;[Epub]     CrossRef
  • Combining Automated Organoid Workflows with Artificial Intelligence‐Based Analyses: Opportunities to Build a New Generation of Interdisciplinary High‐Throughput Screens for Parkinson's Disease and Beyond
    Henrik Renner, Hans R. Schöler, Jan M. Bruder
    Movement Disorders.2021; 36(12): 2745.     CrossRef
  • Is Multiple System Atrophy a Prion-like Disorder?
    Kurt A. Jellinger, Gregor K. Wenning, Nadia Stefanova
    International Journal of Molecular Sciences.2021; 22(18): 10093.     CrossRef
  • Cortical alpha-synuclein preformed fibrils do not affect interval timing in mice
    Qiang Zhang, Hisham Abdelmotilib, Travis Larson, Cameron Keomanivong, Mackenzie Conlon, Georgina M. Aldridge, Nandakumar S. Narayanan
    Neuroscience Letters.2021; 765: 136273.     CrossRef
  • Temporal Evolution of Inflammation and Neurodegeneration With Alpha-Synuclein Propagation in Parkinson's Disease Mouse Model
    Thuy Thi Lai, Yun Joong Kim, Phuong Thi Nguyen, Young Ho Koh, Tinh Thi Nguyen, Hyeo-il Ma, Young Eun Kim
    Frontiers in Integrative Neuroscience.2021;[Epub]     CrossRef
  • The Concept of α-Synuclein Strains and How Different Conformations May Explain Distinct Neurodegenerative Disorders
    Katja Malfertheiner, Nadia Stefanova, Antonio Heras-Garvin
    Frontiers in Neurology.2021;[Epub]     CrossRef
  • A historical review of multiple system atrophy with a critical appraisal of cellular and animal models
    David J. Marmion, Wouter Peelaerts, Jeffrey H. Kordower
    Journal of Neural Transmission.2021; 128(10): 1507.     CrossRef
  • Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines
    Masaru Tanaka, József Toldi, László Vécsei
    International Journal of Molecular Sciences.2020; 21(7): 2431.     CrossRef
  • Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
    Mónica Gómez-Benito, Noelia Granado, Patricia García-Sanz, Anne Michel, Mireille Dumoulin, Rosario Moratalla
    Frontiers in Pharmacology.2020;[Epub]     CrossRef
  • Enhanced Susceptibility of PINK1 Knockout Rats to α-Synuclein Fibrils
    Rose B. Creed, Matthew S. Goldberg
    Neuroscience.2020; 437: 64.     CrossRef
  • Pathogenic Mutations Differentially Regulate Cell-to-Cell Transmission of α-Synuclein
    Yuan Guan, Xiaofang Zhao, Fengwei Liu, Shuxin Yan, Yalong Wang, Cuilian Du, Xiuyu Cui, Rena Li, Claire Xi Zhang
    Frontiers in Cellular Neuroscience.2020;[Epub]     CrossRef
  • Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes
    Alessia Indrieri, Rocco Pizzarelli, Brunella Franco, Elvira De Leonibus
    Frontiers in Neuroscience.2020;[Epub]     CrossRef
  • Classic and evolving animal models in Parkinson's disease
    Tanvi Pingale, Girdhari Lal Gupta
    Pharmacology Biochemistry and Behavior.2020; 199: 173060.     CrossRef
Oro-Pharyngeal Dysphagia in Parkinson’s Disease and Related Movement Disorders
Miseon Kwon, Jae-Hong Lee
J Mov Disord. 2019;12(3):152-160.   Published online September 30, 2019
DOI: https://doi.org/10.14802/jmd.19048
  • 42,041 View
  • 1,145 Download
  • 41 Web of Science
  • 41 Crossref
AbstractAbstract PDFSupplementary Material
Oro-pharyngeal dysphagia is a common symptom in patients with Parkinson’s disease (PD) and related disorders, even in their early stage of diseases. Dysphagia in these patients has been underdiagnosed, probably due to poor the self-awareness of the conditions and the underuse of validated tools and objective instruments for assessment. The early detection and intervention of dysphagia are closely related to improving the quality of life and decreasing the mortality rate in these patients. The purpose of this paper is to give an overview of the characteristics of dysphagia, including the epidemiology, pathophysiology, and clinical symptomatology, in patients with PD compared with other parkinsonian disorders and movement disorders. The management of dysphagia and future research directions related to these disorders are also discussed.

Citations

Citations to this article as recorded by  
  • The missing piece of the puzzle – The key role of the dietitian in the management of Parkinson's disease
    Richelle Flanagan, Carley Rusch, Fiona E. Lithander, Indu Subramanian
    Parkinsonism & Related Disorders.2024; 121: 106021.     CrossRef
  • Quantitative evaluation of swallowing function in Parkinson’s disease using tongue pressure measurement: a mini-review
    Tatsuyuki Fukuoka, Kazuhiro Hori, Takahiro Ono
    Frontiers in Neurology.2024;[Epub]     CrossRef
  • Dysphagia in Parkinson's disease: A bibliometric and visualization analysis from 2002 to 2022
    Weiming Sun, Keqi Wan, Shilin Li, Guojian Shen, Xiangli Dong, Guohua Yu, Zhen Feng, Chafeng Zheng
    Heliyon.2024; 10(9): e30191.     CrossRef
  • Parkinson's disease – The dentist's role as part of the healthcare team
    Liliana Ortiz Camacho, Leila Jahangiri, Jenna Iseringhausen, Gary R. Goldstein
    Journal of Prosthodontics.2024;[Epub]     CrossRef
  • User-centred design, validation and clinical testing of an anti-choking mug for people with Parkinson’s disease
    Roongroj Bhidayasiri, Araya Chaisongkram, Chanawat Anan, Warongporn Phuenpathom
    Scientific Reports.2024;[Epub]     CrossRef
  • Dysphagia Presentation, Airway Invasion, and Gender Differences in a Clinically Based Sample of People with Parkinson’s Disease
    Matthew Dumican, Christopher Watts, Teresa Drulia, Yan Zhang
    Dysphagia.2023; 38(1): 353.     CrossRef
  • An intensive neurorehabilitation programme with sEMG biofeedback to improve swallowing in idiopathic Parkinson's disease (IPD): A feasibility study
    Irene Battel, Margaret Walshe
    International Journal of Language & Communication Disorders.2023; 58(3): 813.     CrossRef
  • Tongue strength and clinical correlations in Parkinson's disease
    Exequiel Plaza, Angela Ruviaro Busanello‐Stella
    Journal of Oral Rehabilitation.2023; 50(4): 300.     CrossRef
  • Pathophysiology of non-motor signs in Parkinson’s disease: some recent updating with brief presentation
    Khaled Radad, Rudolf Moldzio, Christopher Krewenka, Barbara Kranner, Wolf-Dieter Rausch
    Exploration of Neuroprotective Therapy.2023; : 24.     CrossRef
  • Pink1-/- Rats Demonstrate Swallowing and Gastrointestinal Dysfunction in a Model of Prodromal Parkinson Disease
    Maryann N. Krasko, John Szot, Karolina Lungova, Linda M. Rowe, Glen Leverson, Cynthia A. Kelm-Nelson, Michelle R. Ciucci
    Dysphagia.2023; 38(5): 1382.     CrossRef
  • Dysphagia in Parkinson Disease: Part I – Pathophysiology and Diagnostic Practices
    Denis Michael Rudisch, Maryann N. Krasko, Ryan Burdick, Courtney K. Broadfoot, Nicole Rogus-Pulia, Michelle R. Ciucci
    Current Physical Medicine and Rehabilitation Reports.2023; 11(2): 176.     CrossRef
  • Dysphagia Requiring Medical Attention in Parkinson’s Disease: A Korean Population-Based Study
    Seungwoo Cha, Won Kee Chang, Hee-Mun Cho, Kyungdo Han, Nam-Jong Paik, Sohyun Kwon, Won-Seok Kim
    Journal of Korean Medical Science.2023;[Epub]     CrossRef
  • A systematic review and meta-analysis of acupuncture in Parkinson's disease with dysphagia
    Jing Wu, Yi Wang, Xueyan Wang, Yujia Xie, Weihong Li
    Frontiers in Neurology.2023;[Epub]     CrossRef
  • Chaudhuri’s Dashboard of Vitals in Parkinson’s syndrome: an unmet need underpinned by real life clinical tests
    Mubasher A. Qamar, Silvia Rota, Lucia Batzu, Indu Subramanian, Cristian Falup-Pecurariu, Nataliya Titova, Vinod Metta, Iulia Murasan, Per Odin, Chandrasekhara Padmakumar, Prashanth L. Kukkle, Rupam Borgohain, Rukmini Mridula Kandadai, Vinay Goyal, Kallol
    Frontiers in Neurology.2023;[Epub]     CrossRef
  • Orofacial function and temporomandibular disorders in Parkinson’s Disease: a case-controlled study
    Sara Baram, Carsten Eckhart Thomsen, Esben Boeskov Øzhayat, Merete Karlsborg, Merete Bakke
    BMC Oral Health.2023;[Epub]     CrossRef
  • Laryngeal symptoms related to motor phenotypes in Parkinson's disease: A systematic review
    Zoe Thijs, Matthew Dumican
    Laryngoscope Investigative Otolaryngology.2023; 8(4): 970.     CrossRef
  • Transadaptation and Validation of the Telugu Version of the Dysphagia Handicap Index
    Philemon Benison Dasari, Himanshu Verma, Harisha Madishetty, Jothirmai Pagidimarri, Janaki Balaji
    Seminars in Speech and Language.2023; 44(04): 230.     CrossRef
  • Progression of Self-Perceived Speech and Swallowing Impairment in Early Stage Parkinson's Disease: Longitudinal Analysis of the Unified Parkinson's Disease Rating Scale
    Christopher R. Watts, Yan Zhang
    Journal of Speech, Language, and Hearing Research.2022; 65(1): 146.     CrossRef
  • Terminal Choking in Parkinson's Disease
    Andrea Ling, Fiona Herbert, Bethany Wright, Edward Richfield
    Journal of Pain and Symptom Management.2022; 63(6): e757.     CrossRef
  • Effects of a tongue training program in Parkinson's disease: Analysis of electrical activity and strength of suprahyoid muscles
    Exequiel Plaza, Angela Ruviaro Busanello-Stella
    Journal of Electromyography and Kinesiology.2022; 63: 102642.     CrossRef
  • Antidepressants Usage and Risk of Pneumonia Among Elderly Patients With the Parkinson's Disease: A Population-Based Case-Control Study
    Wei-Yin Kuo, Kuang-Hua Huang, Yu-Hsiang Kuan, Yu-Chia Chang, Tung-Han Tsai, Chien-Ying Lee
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Neuropathological Aspects of SARS-CoV-2 Infection: Significance for Both Alzheimer’s and Parkinson’s Disease
    Jaime Silva, Felipe Patricio, Aleidy Patricio-Martínez, Gerardo Santos-López, Lilia Cedillo, Yousef Tizabi, Ilhuicamina Daniel Limón
    Frontiers in Neuroscience.2022;[Epub]     CrossRef
  • Identifying rates and risk factors for medication errors during hospitalization in the Australian Parkinson’s disease population: A 3-year, multi-center study
    Michael Bakker, Michaela E. Johnson, Lauren Corre, Deanna N. Mill, Xingzhuo Li, Richard J. Woodman, Jacinta L. Johnson, Ismaeel Yunusa
    PLOS ONE.2022; 17(5): e0267969.     CrossRef
  • Vegetable finger foods - Preferences among older adults with motoric eating difficulties
    Sarah Forsberg, Viktoria Olsson, Wender L.P. Bredie, Karin Wendin
    International Journal of Gastronomy and Food Science.2022; 28: 100528.     CrossRef
  • Swallow Safety and Laryngeal Kinematics: A Comparison of Dysphagia Between Parkinson’s Disease and Cerebrovascular Accident
    Matthew Dumican, Christopher Watts
    Journal of Parkinson's Disease.2022; : 1.     CrossRef
  • Parkinson Hastalığında Yutma Bozukluklarına Yaklaşım
    Merve SAPMAZ ATALAR, Gençer GENÇ
    Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi.2022; 9(2): 189.     CrossRef
  • Swallow Safety and Laryngeal Kinematics: A Comparison of Dysphagia Between Parkinson’s Disease and Cerebrovascular Accident
    Matthew Dumican, Christopher Watts
    Journal of Parkinson's Disease.2022; 12(7): 2147.     CrossRef
  • The prevalence and associated factors of dysphagia in Parkinson's disease: A systematic review and meta-analysis
    Siyuan Gong, Yan Gao, Jihong Liu, Jia Li, Xueqin Tang, Qian Ran, Rongzhu Tang, Chunlian Liao
    Frontiers in Neurology.2022;[Epub]     CrossRef
  • Cardiac sympathetic denervation could be associated with dysphagia in Parkinson's disease
    Jinyoung Youn, George Umemoto, Eungseok Oh, Jinse Park, Wooyoung Jang, Yoon-Sang Oh, Hee-Tae Kim, Jin Whan Cho, Shinsuke Fujioka, Yoshio Tsuboi
    Frontiers in Neurology.2022;[Epub]     CrossRef
  • Sensory preferences and requirements amongst Swedish older adults with motoric eating difficulties
    Sarah Forsberg, Wender Bredie, Karin Wendin
    Food & Nutrition Research.2022;[Epub]     CrossRef
  • Effectiveness of pharmacologic treatment for dysphagia in Parkinson’s disease: a narrative review
    Min Cheol Chang, Jin-Sung Park, Byung Joo Lee, Donghwi Park
    Neurological Sciences.2021; 42(2): 513.     CrossRef
  • The Effect of Deep Brain Stimulation on Swallowing Function in Parkinson’s Disease: A Narrative Review
    Min Cheol Chang, Jin-Sung Park, Byung Joo Lee, Donghwi Park
    Dysphagia.2021; 36(5): 786.     CrossRef
  • Assessment of real life eating difficulties in Parkinson’s disease patients by measuring plate to mouth movement elongation with inertial sensors
    Konstantinos Kyritsis, Petter Fagerberg, Ioannis Ioakimidis, K. Ray Chaudhuri, Heinz Reichmann, Lisa Klingelhoefer, Anastasios Delopoulos
    Scientific Reports.2021;[Epub]     CrossRef
  • Is Dysphagia in Older Patients with Parkinson’s Disease Associated With Sarcopenia?
    Ebru Umay, Z.A. Yigman, E.A. Ozturk, I. Gundogdu, B.G. Koçer
    The Journal of nutrition, health and aging.2021; 25(6): 742.     CrossRef
  • Does Etiology Matter? Comparative Analysis of a Singing-Enhanced Swallowing Protocol for Patients with Neurological Impairment versus Head and Neck Cancer
    Myung Sun Yeo, Ga Eul Yoo, Sung-Rae Cho, Soo Ji Kim
    Brain Sciences.2021; 11(8): 997.     CrossRef
  • Pneumonia Risk Associated with the Use of Individual Benzodiazepines and Benzodiazepine Related Drugs among the Elderly with Parkinson’s Disease
    Kuang-Hua Huang, Chih-Jaan Tai, Yu-Hsiang Kuan, Yu-Chia Chang, Tung-Han Tsai, Chien-Ying Lee
    International Journal of Environmental Research and Public Health.2021; 18(17): 9410.     CrossRef
  • Videofluoroscopic study of swallowing disorders in patients with parkinsonism
    Shivani Rajeev, Sureshkumar Radhakrishnan, Sivakumar Vidhyadharan, Unnikrishnan Menon, Krishnakumar Thankappan, Subramania Iyer
    Amrita Journal of Medicine.2021; 17(3): 93.     CrossRef
  • Dysphagia in Parkinson’s disease: Analysis of screening questionnaire and videofluoroscopy findings
    RavichandranSumathi Aarthi, SureshKumar Radhakrishnan, Sivakumar Vidhyadharan, UnnikrishnanK Menon, ChandrababuJaya Arya, Krishnakumar Thankappan
    Annals of Movement Disorders.2021; 4(2): 73.     CrossRef
  • Predicting Airway Invasion Using Screening Tools and Laryngeal Kinematics in People with Parkinson’s Disease: A Pilot Study
    Matthew Dumican, Christopher Watts
    Journal of Parkinson's Disease.2020; 10(3): 1153.     CrossRef
  • A comprehensive review of the diagnosis and treatment of Parkinson’s disease dysphagia and aspiration
    Bhavana Patel, Joseph Legacy, Karen W. Hegland, Michael S. Okun, Nicole E. Herndon
    Expert Review of Gastroenterology & Hepatology.2020; 14(6): 411.     CrossRef
  • Pramipexole thermosensitive nasal gel for experimental parkinsonism in rats
    Vinay Sridhar, Ankit Tiwari, Sarika Wairkar, Girdhari Lal Gupta, Ram Gaud
    Journal of Drug Delivery Science and Technology.2020; 59: 101954.     CrossRef
Viewpoint
Recent Advances in the Development of Experimental Therapeutics for Levodopa-Induced Dyskinesia
Michael L. Martini, Sean N. Neifert, J Mocco, Fedor Panov, Winona Tse, Ruth H. Walker, Jian Jin, Fiona Gupta
J Mov Disord. 2019;12(3):161-165.   Published online September 30, 2019
DOI: https://doi.org/10.14802/jmd.19029
  • 6,589 View
  • 200 Download
  • 2 Web of Science
  • 1 Crossref
PDF

Citations

Citations to this article as recorded by  
  • Antioxidant Effect of Alpha-Lipoic Acid in 6-Hydroxydopamine Unilateral Intrastriatal Injected Rats
    Pavlina Andreeva-Gateva, Lubomir Traikov, Zafer Sabit, Dimitar Bakalov, Radka Tafradjiiska-Hadjiolova
    Antioxidants.2020; 9(2): 122.     CrossRef
Original Articles
Increased Signal in the Superior Cerebellar Peduncle of Patients with Progressive Supranuclear Palsy
Hiroshi Kataoka, Yukako Nishimori, Takao Kiriyama, Hitoki Nanaura, Tesseki Izumi, Nobuyuki Eura, Naoki Iwasa, Kazuma Sugie
J Mov Disord. 2019;12(3):166-171.   Published online August 9, 2019
DOI: https://doi.org/10.14802/jmd.19002
  • 8,729 View
  • 220 Download
  • 2 Web of Science
  • 2 Crossref
AbstractAbstract PDF
Objective
The provisional diagnosis of progressive supranuclear palsy (PSP) depends on a combination of typical clinical features and specific MRI findings, such as atrophy of the tegmentum in the midbrain. Atrophy of the superior cerebellar peduncle (SCP) distinguishes PSP from other types of parkinsonism. Histological factors affect the conventional fluid-attenuated inversion recovery (FLAIR) signals, such as the extent of neuronal loss and gliosis.
Methods
We investigated patients with PSP to verify the percentage of patients with various PSP phenotypes presenting a high signal intensity in the SCP. Three interviewers, who were not informed about the clinical data, visually inspected the presence or absence of a high signal intensity in the SCP on the FLAIR images. We measured the pixel value in the SCP of each patient. Clinical characteristics were evaluated using the Mann-Whitney test, followed by the χ2 test.
Results
Ten of the 51 patients with PSP showed a high signal intensity in the SCP on FLAIR MRI. Higher pixel values were observed within the SCP of patients with a high signal intensity in the SCP than in patients without a high signal intensity (p < 0.001). The sensitivity and specificity of the high signal intensity in the SCP of patients with PSP was 19.6% and 100%, respectively. This finding was more frequently observed in patients with PSP with Richardson’s syndrome (PSP-RS) (25.7%) than other phenotypes (6.2%).
Conclusion
The high signal intensity in the SCP on FLAIR MRI might be an effective diagnostic tool for PSP-RS.

Citations

Citations to this article as recorded by  
  • Diffusion tractography of superior cerebellar peduncle and dentatorubrothalamic tracts in two autopsy confirmed progressive supranuclear palsy variants: Richardson syndrome and the speech-language variant
    Rodolfo G. Gatto, Peter R. Martin, Farwa Ali, Heather M. Clark, Joseph R. Duffy, Rene L. Utianski, Hugo Botha, Mary M. Machulda, Dennis W. Dickson, Keith A. Josephs, Jennifer L. Whitwell
    NeuroImage: Clinical.2022; 35: 103030.     CrossRef
  • The Role of Magnetic Resonance Imaging for the Diagnosis of Atypical Parkinsonism
    Lydia Chougar, Nadya Pyatigorskaya, Bertrand Degos, David Grabli, Stéphane Lehéricy
    Frontiers in Neurology.2020;[Epub]     CrossRef
The Impact of Impulsivity on Quality of Life in Early Drug-Naïve Parkinson’s Disease Patients
Dong-Woo Ryu, Joong-Seok Kim, Sang-Won Yoo, Yoon-Sang Oh, Kwang-Soo Lee
J Mov Disord. 2019;12(3):172-176.   Published online August 9, 2019
DOI: https://doi.org/10.14802/jmd.19004
Correction in: J Mov Disord 2021;14(2):176
  • 5,522 View
  • 108 Download
  • 7 Web of Science
  • 6 Crossref
AbstractAbstract PDF
Objective
Impulse control disorders (ICDs) in Parkinson’s disease (PD) are mostly related to dopamine replacement therapy (DRT); however, drug-naïve PD patients have also frequently experienced impulsivity. This phenomenon makes clinicians hesitate treating patients with DRT. In this study, we assessed the effect of impulsivity on quality of life (QOL) in drug-naïve PD patients.
Methods
Two hundred three newly diagnosed, nonmedicated PD patients were enrolled, and they received structured clinical interviews, physical examinations and validated questionnaires to evaluate motor and nonmotor symptoms and QOL. Impulsivity was evaluated using the Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease-Rating Scale (QUIP-RS).
Results
Thirty-eight patients (18.7%) had impulsivity with QUIP-RS scores ≥ 1 and 4 patients (2.0%) were diagnosed with combined ICDs. Motor and nonmotor symptoms were significantly correlated with the Parkinson’s Disease Questionnaire-39 summary index. Female sex and QUIP-RS scores were also correlated with QOL in drug-naïve PD patients.
Conclusion
The results of the present study showed that impulsivity negatively influences QOL in early drug-naïve PD patients. In addition, more severe motor and nonmotor symptoms were also associated with lower QOL. Such findings complicate treatment but provide valuable information for managing early PD.

Citations

Citations to this article as recorded by  
  • Frequency of Impulsive-Compulsive Behavior and Associated Psychological Factors in Parkinson’s Disease: Lack of Control or Too Much of It?
    Alexandros Kapsomenakis, Dimitrios Kasselimis, Emily Vaniotis, Anastasia Bougea, Christos Koros, Athina Maria Simitsi, Leonidas Stefanis, Constantin Potagas
    Medicina.2023; 59(11): 1942.     CrossRef
  • Locus Coeruleus Integrity Is Linked to Response Inhibition Deficits in Parkinson's Disease and Progressive Supranuclear Palsy
    Rong Ye, Frank H. Hezemans, Claire O'Callaghan, Kamen A. Tsvetanov, Catarina Rua, P. Simon Jones, Negin Holland, Maura Malpetti, Alexander G. Murley, Roger A. Barker, Caroline H. Williams-Gray, Trevor W. Robbins, Luca Passamonti, James B. Rowe
    The Journal of Neuroscience.2023; 43(42): 7028.     CrossRef
  • Neuropsychiatric Symptoms in Parkinson's Disease After Subthalamic Nucleus Deep Brain Stimulation
    Weibing Liu, Tatsuya Yamamoto, Yoshitaka Yamanaka, Masato Asahina, Tomoyuki Uchiyama, Shigeki Hirano, Keisuke Shimizu, Yoshinori Higuchi, Satoshi Kuwabara
    Frontiers in Neurology.2021;[Epub]     CrossRef
  • Dopamine genetic risk score predicts impulse control behaviors in Parkinson’s disease
    Alison Hall, Samuel R. Weaver, Lindsey J. Compton, Winston D. Byblow, Ned Jenkinson, Hayley J. MacDonald
    Clinical Parkinsonism & Related Disorders.2021; 5: 100113.     CrossRef
  • A Review of the Concept of Impulsivity
    Mohammed Munther Al-Hammouri, Jehad A. Rababah, Celeste Shawler
    Advances in Nursing Science.2021; 44(4): 357.     CrossRef
  • Assessment of therapeutic strategies for management of impulse control disorder in Parkinson’s disease
    Mayela Rodríguez-Violante, Yazmín Ríos-Solís, Oscar Esquivel-Zapata, Fanny Herrera, Susana López-Alamillo, Cynthia Sarabia-Tapia, Amin Cervantes-Arriaga
    Arquivos de Neuro-Psiquiatria.2021; 79(11): 989.     CrossRef
Clinical Milestones Preceding the Diagnosis of Multiple System Atrophy and Progressive Supranuclear Palsy: A Retrospective Cohort Study
Louise Wiblin, Rory Durcan, Brook Galna, Mark Lee, David Burn
J Mov Disord. 2019;12(3):177-183.   Published online August 9, 2019
DOI: https://doi.org/10.14802/jmd.19015
  • 7,875 View
  • 218 Download
  • 4 Web of Science
  • 6 Crossref
AbstractAbstract PDF
Objective
Multiple System Atrophy (MSA) and progressive supranuclear palsy (PSP) are rapidly progressive forms of degenerative Parkinsonism. The difficulties of diagnosing MSA and PSP in their early stages may lead to delayed referral to appropriate specialists and distress to patients, as well as delaying symptomatic treatment and participation in clinical trials. This work aimed to describe the symptoms that patients with MSA and PSP developed and plot their emergence relative to final diagnosis using a median onset in months.
Methods
Forty-seven patients from the United Kingdom with MSA or PSP diagnosed by a movement disorder specialist were interviewed with carers or relatives to establish milestone onset. This was corroborated using clinical notes and letters.
Results
In the MSA cohort (n = 23), autonomic symptoms (median 5.5 months before diagnosis) and falls (median 1 month before diagnosis) were the two clinical milestones which occurred before diagnosis. In the PSP cohort (n = 24), falling was the only milestone which occurred before diagnosis (median of 18.5 months).
Conclusion
This Study Shows That Psp Patients Experience Falling More Than A Year And A Half An Average Before Receiving A Diagnosis And Although Msa Patients Also Tended To Fall, This Was Much Closer To The Time Of Diagnosis. Further Work With Larger Cohorts May Illustrate Whether These Preliminary Findings Can Be Generalised To Guide Diagnosis And Management.

Citations

Citations to this article as recorded by  
  • Progressive Supranuclear palsy (PSP) disease progression, management, and healthcare resource utilization: a retrospective observational study in the US and Canada
    Ella Nysetvold, Lauren N. Lopez, Ashley N. Cogell, Henrik Fryk, Nelson D. Pace, Sara Snell Taylor, Joyce Rhoden, Caitlin A. Nichols, Demetris Pillas, Alexander Klein, Teresa Gasalla, Anna Scowcroft
    Orphanet Journal of Rare Diseases.2024;[Epub]     CrossRef
  • Clinical milestones as triggers for palliative care intervention in progressive Supranuclear palsy and multiple system atrophy
    Robin Bessemer, Alla Iansavichene, Mary E. Jenkins, Elizabeth Finger, Teneille E. Gofton
    Journal of the Neurological Sciences.2023; 448: 120614.     CrossRef
  • Toward More Accessible Fully Automated 3D Volumetric MRI Decision Trees for the Differential Diagnosis of Multiple System Atrophy, Related Disorders, and Age-Matched Healthy Subjects
    Jisoo Kim, Geoffrey S. Young, Andrew S. Willett, Ariana T. Pitaro, Grace F. Crotty, Merlyne Mesidor, Kristie A. Jones, Camden Bay, Min Zhang, Mel B. Feany, Xiaoyin Xu, Lei Qin, Vikram Khurana
    The Cerebellum.2022; 22(6): 1098.     CrossRef
  • Disease course and treatment patterns in progressive supranuclear palsy: A real-world study
    John C. Morgan, Xiaolan Ye, Jennifer A. Mellor, Keisha J. Golden, Jorge Zamudio, Louis A. Chiodo, Yanjun Bao, Tao Xie
    Journal of the Neurological Sciences.2021; 421: 117293.     CrossRef
  • Patient and care partner views on exercise and structured physical activity for people with Progressive Supranuclear Palsy
    Susan C. Slade, Christopher Bruce, Jennifer L. McGinley, Bastiaan R. Bloem, Meg E. Morris, John Duda
    PLOS ONE.2020; 15(6): e0234265.     CrossRef
  • Effect of cold oral stimulation on orthostatic hypotension in multiple system atrophy: a case study
    Hironobu Uzawa, Shinta Takeuchi, Yusuke Nishida
    Journal of Physical Therapy Science.2020; 32(7): 473.     CrossRef
Letters to the editor
Fragile X-Associated Tremor/Ataxia Syndrome: An Illustrative Case
Chaewon Lee, Kye Won Park, Nari Choi, Ho-Sung Ryu, Sun Ju Chung
J Mov Disord. 2019;12(3):184-186.   Published online July 17, 2019
DOI: https://doi.org/10.14802/jmd.18060
  • 5,809 View
  • 120 Download
  • 2 Web of Science
  • 2 Crossref
PDF

Citations

Citations to this article as recorded by  
  • A Case of Fragile-X-Associated Tremor/Ataxia Syndrome Without Tremor
    Woong-Woo Lee, Byung-Kun Kim, Jung Ju Lee, Kyusik Kang
    Journal of Clinical Neurology.2023; 19(5): 498.     CrossRef
  • Brain 18F-FDG and 18F-Flumetamol PET Imaging of Fragile X-Associated Tremor Ataxia Syndrome
    Ruggero Bacchin, Matteo Salgarello, Michela Trentin, Giampietro Zanette, Stefano Tamburin
    Clinical Nuclear Medicine.2021; 46(7): e344.     CrossRef
Hyperglycemia-Associated Hemichorea-Hemiballismus with Predominant Ipsilateral Putaminal Abnormality on Neuroimaging
Si Lei Fong, Ai Huey Tan, Kar Foo Lau, Norlisah Ramli, Shen-Yang Lim
J Mov Disord. 2019;12(3):187-189.   Published online August 9, 2019
DOI: https://doi.org/10.14802/jmd.19014
  • 6,993 View
  • 170 Download
  • 7 Web of Science
  • 5 Crossref
PDFSupplementary Material

Citations

Citations to this article as recorded by  
  • Relationship Between Diabetic Chorea and Timing of MRI Findings: A Systematic Review with Case Reports
    Yumi Otaka, Yukinori Harada, Norio Sugawara, Taro Shimizu, Norio Yasui-Furukori
    International Journal of General Medicine.2023; Volume 16: 4465.     CrossRef
  • The Possible Precipitating Role of SARS-CoV-2 in a Case of Late-Onset Hemichorea Due to a Hyperosmolar Hyperglycemic State: Case Report and Brief Literature Review
    Roberto Sperotto, Laura Ceccarelli, Yan Tereshko, Giovanni Merlino, Gian Luigi Gigli, Mariarosaria Valente
    Medicina.2023; 59(11): 1949.     CrossRef
  • Consideration for Hemiballismus in the Differential Diagnosis: A Rare Case of Hyperosmolar Hyperglycemic State
    Iman Isayli, Nicolas Ulloa, John Childress
    Cureus.2022;[Epub]     CrossRef
  • A Case of Diabetic Hemichorea Hemiballismus Exacerbated by Hypoglycemia
    Jessica Rupp, Avrum Gillespie
    AACE Clinical Case Reports.2021;[Epub]     CrossRef
  • Hemicorea inducida por hiperglucemia no cetósica: discordancia clínicorradiológica
    Juan Pablo García Marmolejo, Manuel David Mayoral Valencia, Paola Andrea Tejada Serna
    Universitas Médica.2021;[Epub]     CrossRef
Successful Pallidal Deep Brain Stimulation in a Patient with Childhood-Onset Generalized Dystonia with ANO3 Mutation
Dallah Yoo, Han-Joon Kim, Jong-Hee Chae, Sun Ha Paek, Beomseok Jeon
J Mov Disord. 2019;12(3):190-191.   Published online July 17, 2019
DOI: https://doi.org/10.14802/jmd.19016
  • 5,510 View
  • 122 Download
  • 9 Web of Science
  • 9 Crossref
PDFSupplementary Material

Citations

Citations to this article as recorded by  
  • The Clinical Spectrum of ANO3—Report of a New Family and Literature Review
    Marco Percetti, Michela Zini, Paola Soliveri, Filippo Cogiamanian, Mariarosa Ferrara, Eva Orunesu, Alessandra Ranghetti, Carlo Ferrarese, Gianni Pezzoli, Barbara Garavaglia, Ioannis Ugo Isaias, Giorgio Sacilotto
    Movement Disorders Clinical Practice.2024; 11(3): 289.     CrossRef
  • The role of genetics in the treatment of dystonia with deep brain stimulation: Systematic review and Meta-analysis
    Harini Sarva, Federico Rodriguez-Porcel, Francisco Rivera, Claudio Daniel Gonzalez, Samantha Barkan, Susmit Tripathi, Emilia Gatto, Pedro Garcia Ruiz
    Journal of the Neurological Sciences.2024; 459: 122970.     CrossRef
  • A novel ANO3 variant in two siblings with different phenotypes
    Marcello Esposito, Assunta Trinchillo, Francesca Piceci-Sparascio, Maria Cecilia D'Asdia, Federica Consoli, Alessandro De Luca
    Parkinsonism & Related Disorders.2023; 111: 105413.     CrossRef
  • DBS-Evoked Pallidal Activity Correlates with Clinical Improvement in a Patient with ANO3-Related Dystonia
    Aditya Boddu, Adam Bashir, Mohammad Awad, Barton Guthrie, Harrison Walker
    SSRN Electronic Journal.2023;[Epub]     CrossRef
  • Deep Brain Stimulation in Dystonia: Disentangling Heterogeneity
    Alberto Albanese
    Movement Disorders Clinical Practice.2021; 8(1): 6.     CrossRef
  • Pallidal Deep Brain Stimulation for Monogenic Dystonia: The Effect of Gene on Outcome
    Stephen Tisch, Kishore Raj Kumar
    Frontiers in Neurology.2021;[Epub]     CrossRef
  • The expanding clinical and genetic spectrum of ANO3 dystonia
    Li-Ting Jiang, Li-Xi Li, Ying Liu, Xiao-Long Zhang, You-Gui Pan, Lin Wang, Xin-Hua Wan, Ling-Jing Jin
    Neuroscience Letters.2021; 746: 135590.     CrossRef
  • Huntington disease-like phenotype in a patient with ANO3 mutation
    Shahedah Koya Kutty, Eoin Mulroy, Francesca Magrinelli, Giulia Di Lazzaro, Anna Latorre, Kailash P. Bhatia
    Parkinsonism & Related Disorders.2021; 90: 120.     CrossRef
  • Arching deep brain stimulation in dystonia types
    Han-Joon Kim, Beomseok Jeon
    Journal of Neural Transmission.2021; 128(4): 539.     CrossRef
Benefits of Levodopa-Carbidopa Intestinal Gel Infusion in Patients with Parkinson’s Disease Experiencing Gait Dysfunction Following Subthalamic Deep Brain Stimulation
Thomas Edmund Kimber, YiZhong Zhuang, Philip Douglas Thompson
J Mov Disord. 2019;12(3):192-194.   Published online September 30, 2019
DOI: https://doi.org/10.14802/jmd.19022
  • 4,597 View
  • 68 Download
  • 2 Web of Science
  • 2 Crossref
PDFSupplementary Material

Citations

Citations to this article as recorded by  
  • Nationwide Retrospective Analysis of Combinations of Advanced Therapies in Patients With Parkinson Disease
    Dominik Pürner, Mohammad Hormozi, Daniel Weiß, Michael T. Barbe, Hannah Jergas, Tino Prell, Eileen Gülke, Monika Pötter-Nerger, Björn Falkenburger, Lisa Klingelhöfer, Pia K. Gutsmiedl, Bernhard Haslinger, Angela M. Jochim, Andreas Wolff, Nils Schröter, Mi
    Neurology.2023;[Epub]     CrossRef
  • Combined and Sequential Treatment with Deep Brain Stimulation and Continuous Intrajejunal Levodopa Infusion for Parkinson’s Disease
    Daniël van Poppelen, Annelie N.M. Tromp, Rob M.A. de Bie, Joke M. Dijk
    Journal of Personalized Medicine.2021; 11(6): 547.     CrossRef
Hemichorea-Hemiballism after External Ventricular Drainage
Mirza Masoom Abbas, Ravi Gopal Varma, Nirmala Sankar, Raghavendra Pai
J Mov Disord. 2019;12(3):195-197.   Published online September 30, 2019
DOI: https://doi.org/10.14802/jmd.19033
  • 4,585 View
  • 61 Download
  • 1 Web of Science
  • 1 Crossref
PDFSupplementary Material

Citations

Citations to this article as recorded by  
  • Efficacy and safety profile of neuroendoscopic hematoma evacuation combined with intraventricular lavage in severe intraventricular hemorrhage patients
    Hai‐Tao Ding, Yao Han, De‐Ke Sun, Quan‐Min Nie
    Brain and Behavior.2020;[Epub]     CrossRef

JMD : Journal of Movement Disorders Twitter